Lab-Grown Tumors Could Uncover New Mesothelioma Treatments

Experts are always looking for new cancer treatments to increase the survival rates of mesothelioma patients. One new study that involves growing tumors in a lab could provide breakthrough research for improving mesothelioma treatment.

Researchers at the University of California Los Angeles (UCLA) are creating tiny tumor organoids from surgery patients’ cells and testing the effectiveness of specific drugs on the replica tumors. The study, which was published on the Communications Biology website, included four people. One of the patients had a rare form of ovarian cancer, and tests showed that the cyclin-kinase inhibitors drug class (which combat overproliferation of cancerous cells) effectively stopped the replica ovarian cancer tumor from growing.

If the study continues, researchers could uncover a new drug for mesothelioma treatment. Doing so would be a groundbreaking discovery for the medical field — and could improve the life expectancy of the approximately 3,000 Americans diagnosed each year with mesothelioma.

Current Treatments for Mesothelioma

There are currently few treatment options for cancer. Most mesothelioma patients rely on chemotherapy. Other approaches are radiation and — if the mesothelioma tumor is in an early stage — surgery. While chemotherapy has saved many lives, it’s not always effective.

According to the American Cancer Society, the two-year survival rate for Stage 1 of pleural mesothelioma, the most common type of the illness, is between 41% and 46%. The five-year survival rate is 16%, and the survival rates drop for patients with more progressive stages of the illness.

Chemotherapy involves powerful medications that kill cancerous cells in the body. The drugs specifically look for cells growing at a rapid rate, which is a primary characteristic of cancer spreading.

However, there are non-cancerous cells that proliferate, and chemotherapy drugs can target these essential cells and result in severe, even deadly, side effects. The risk factors associated with chemotherapy are why scientists want to find additional mesothelioma treatment methods.

There are numerous tests and clinical trials attempting to uncover new drugs for mesothelioma treatment. Visit the Mesothelioma Guide clinical trial database to learn more information about the ongoing studies, including how to participate to help mesothelioma treatment improve.

Devin Golden

Devin Golden is the content writer for Mesothelioma Guide. He produces mesothelioma-related content on various mediums, including the Mesothelioma Guide website and social media channels. Devin's objective is to translate complex information regarding mesothelioma into informative, easily absorbable content to help patients and their loved ones.

Share
    Published by
    Devin Golden

    Recent Posts

    Can You Identify Each Mesothelioma Cell Type?

    Mesothelioma is a challenging disease to understand. The cancer is rare, largely unheard of, and doesn’t form on any well-known…

    17 hours ago

    Can You Have Both Pleural Mesothelioma and Peritoneal Mesothelioma?

    Almost all mesothelioma cases start in one of two areas: the pleura or the peritoneum. Hence, the two most common…

    2 days ago

    9/11-Related Mesothelioma Deaths Have Started

    In the aftermath of 9/11, medical experts worried about the long-term health ramifications. The people in lower Manhattan that day…

    1 week ago

    Lung Cancer Awareness Month: 10 Facts About Asbestos Lung Cancer

    Asbestos is a carcinogen linked to numerous diseases. If you’ve visited our website before, then you likely know the mineral…

    1 week ago

    Proton Radiation Surging as a Mesothelioma Treatment

    Experts continue exploring new treatment options for mesothelioma patients. Some ideas aren’t brand new but are tweaks to current forms…

    1 week ago

    Linking Automobile Work to Mesothelioma

    Have you ever thought of automobile brakes as a source of asbestos exposure and occupation linked to mesothelioma? If not,…

    2 weeks ago